Related Experiment Videos
Changes in protein expression in p53 deleted spontaneous thymic lymphomas.
Bent Honoré1, Henrik Vorum, Anders Elm Pedersen
1Department of Medical Biochemistry, University of Aarhus, DK-8000 Aarhus C, Denmark. bh@biokemi.au.dk
Experimental Cell Research
|March 31, 2004
Summary
Mice lacking the p53 gene show altered cellular protein expression, particularly in thymic lymphoma cells. This p53 deficiency leads to tumor-specific genetic dysfunctions and increased expression of specific proteins like acidic ribosomal phosphoprotein P0.
Area of Science:
- Molecular Biology
- Cancer Research
- Proteomics
Background:
- The p53 protein is a critical tumor suppressor involved in cell cycle regulation and apoptosis.
- Loss of p53 function is common in various cancers, leading to genomic instability and uncontrolled cell proliferation.
- Understanding protein expression changes in p53-deficient cells is crucial for identifying cancer mechanisms and therapeutic targets.
Purpose of the Study:
- To compare cellular protein expression profiles in p53-positive and p53-deficient mouse thymocytes and derived lymphomas.
- To identify specific proteins with altered expression levels due to p53 deficiency.
- To investigate whether protein expression changes are common or tumor-specific in p53-deficient lymphomas.
Main Methods:
- High-resolution two-dimensional gel electrophoresis to separate and visualize cellular proteins.
- Computerized image analysis to quantify protein expression levels.
- Mass spectrometry for identification of differentially expressed proteins.
Main Results:
- Approximately 1500 proteins were detected, with 3-5% showing differential regulation in p53-deficient thymic lymphoma cells compared to normal thymocytes.
- Only 13 differentially expressed proteins were common to both analyzed lymphoma cell lines, indicating tumor-specific alterations.
- Two proteins, acidic ribosomal phosphoprotein P0 and a glyoxalase-bleomycin resistance protein family member, showed over 10-fold increased expression in p53-deficient thymocytes and lymphomas.
Conclusions:
- p53 deficiency in mouse thymocytes leads to significant, yet largely individual, protein expression changes in developing lymphomas.
- The observed protein alterations suggest that p53 loss primarily drives tumor development through tumor-specific genetic dysfunctions.
- Acidic ribosomal phosphoprotein P0 and a glyoxalase-bleomycin resistance protein family member are potential biomarkers for p53-deficient thymic lymphomas.